PSYCHIATRIC CLINICS OF NORTH AMERICA
PSYCHIATRIC CLINICS OF NORTH AMERICA(英文缩写 PSYCHIAT CLIN N AM),ISSN 0193-953X,eISSN 1558-3147 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
指标来源：jcr_cas_ifqb
期刊简介
暂无简介。
历年影响因子趋势
| 年份 | 影响因子 | JCR 分区 |
|---|---|---|
| - | Q3 | |
| - | Q4 | |
| - | Q3 | |
| - | Q2 | |
| - | Q2 |
PSYCHIATRIC CLINICS OF NORTH AMERICA 最新收录文献
※ 中文译文由 AI 辅助生成,仅供学术参考,请以英文原文为准。
-
Pharmacogenetic studies of antidepressant response: how far from the clinic?
Because the US FDA has begun to focus on disclosure of pharmacogenetic testing results in applications for new drug approval and review of existing drugs (see, eg, http://www.fda.gov/OHRMS/DOCKETS/AC/…
-
The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder.
Recent studies have shown overall accuracy rates of 72% and 88% using baseline and/or 1-week change in QEEG biomarkers to predict clinical outcome to treatment with various antidepressant medications.…
-
Brain correlates of antidepressant treatment outcome from neuroimaging studies in depression.
Although neutral-state functional neuroimaging studies have improved the understanding of the pathophysiology of major depression, studies that employ state manipulations may provide further informati…
-
Treating depression in the medically ill.
Depression frequently is comorbid with a variety of medical illnesses; individuals who have such comorbidities may have increased morbidity and lower functional status. Usual antidepressant treatments…
-
Comorbid alcohol and substance abuse dependence in depression: impact on the outcome of antidepressant treatment.
Major depressive disorder often co-occurs with substance use disorders, especially alcohol use disorders, and the course of each of these problems seems be complicated by the other. Diagnosing and tre…
-
Update and critique of natural remedies as antidepressant treatments.
Natural medications such as St. John's Wort, SAMe, and omega-3 fatty acids eventually may prove to be valuable additions to the psychiatrist's pharmacologic armamentarium, both as monotherapy and as a…
-
Cognitive and behavioral therapies for depression: overview, new directions, and practical recommendations for dissemination.
Cognitive-behavioral therapy (CBT) is a nonpharmacologic strategy for depression treatment that has received considerable empirical support. This article provides an overview of the history and core t…
-
Somatic therapies for treatment-resistant depression: new neurotherapeutic interventions.
This brief review provides an overview of neurotherapeutic interventions for major depression that are available currently or are being studied in clinical trials. The growing utility of surgical and …
-
A critical overview of the pharmacologic management of treatment-resistant depression.
Major depressive disorder is a frequent, serious disorder that usually responds partially to treatment and leaves many patients with treatment resistance. This article reviews and critically evaluates…
-
The molecular neurobiology of depression. 抑郁症的分子神经生物学
Depression is a condition with a complex biologic pattern in etiology. Environmental stressors modulate subsequent vulnerability to depression. In particular, early adversity seems to induce heightene…